Cohort Study Of Venous Thromboembolism And Other Clinical Endpoints Among Osteoporotic Women Prescribed Bazedoxifene, Bisphosphonates Or Raloxifene In Europe.

Trial Profile

Cohort Study Of Venous Thromboembolism And Other Clinical Endpoints Among Osteoporotic Women Prescribed Bazedoxifene, Bisphosphonates Or Raloxifene In Europe.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Mar 2016

At a glance

  • Drugs Bazedoxifene (Primary) ; Bisphosphonates; Raloxifene
  • Indications Postmenopausal osteoporosis
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 16 Mar 2016 Planned patient no is drastically decreased from 10,750 to 1 and age group of patients is changed from adult & elderly (min 45 years) to adolescent, adult, child, infant, neonate (no specification) as per ClinicalTrials.gov record.
    • 16 Mar 2016 Planned number of patients changed from 10750 to 1 as per ClinicalTrials.gov record.
    • 13 Apr 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top